Navigation Links
Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Parties’ Submission of Bellwether Trial Proposals in Federal Biomet Hip Replacement Litigation
Date:11/18/2013

New York, NY (PRWEB) November 18, 2013

More than 700 Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) filed on behalf of patients who were allegedly injured by the Biomet M2a Magnum Hip Replacement System continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to court records, the parties have submitted proposals for the litigation’s bellwether trial process. The proposal submitted by Plaintiffs’ attorneys would allow for those trials to begin in March 2016, while the Defense proposal would have the first trials start in late 2014. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“Bellwether trials are an important step in any multidistrict litigation, and will help to gauge how juries might rule in similar Biomet hip replacement claims. We are pleased to see these cases moving towards this milestone,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by the Biomet M2a Magnum Hip Replacement System.

Biomet Hip Replacement System
Court records indicate that at least 725 Biome hip lawsuits involving the M2a Magnum hip are pending in the federal multidistrict litigation underway in Indiana. Accordint to court documents, plaintiffs in these lawsuits allege that the metal-on-metal design of the M2a hip allows dangerous amounts of toxic chromium and cobalt particles to be shed into recipients’ tissue and blood stream. This action may cause recipients of the M2a Magnum to suffer metallosis and other serious complications that result in failure of the device and need for revision surgery. Among other things, court filings indicate that Biomet hip replacement plaintiffs claim that the M2a Magnum had been associated with early failures shortly after being launched on the market, and should have been subject to a recall.

Metal-on-metal hip implants were the subject of a U.S. Food & Drug Administration (FDA) warning earlier this year, when the agency cautioned that such devices appeared to be associated with higher rates of failure than hips made from other materials. According to the FDA, all-metal hip recipients should undergo testing for elevated levels of metal ions in their blood if they experience symptoms of a failing hip implant, including pain, swelling around the joint, difficulty walking, and popping, clicking, or squeaking sounds emanating from the hip. The agency has also proposed new regulations that would make metal-on-metal hips ineligible for the agency’s 510(k) clearance program, which allowed the devices to come to market without premarket clinical testing. The proposed regulations would also require the manufacturers of metal-on-metal hips already on the market to conduct safety studies of those products in order to keep selling them.

Individuals who allegedly suffered serious and debilitating complications associated with the
Biomet M2a Hip Replacement System may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about the complications potentially associated with metal-on-metal hip implants, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-hip-replacement/prweb11344981.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biomet Hip Lawsuit News: Rottenstein Law Group LLP Discusses Canadian M2A Magnum Class Action
2. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Filing of Biomet Hip Replacement Class Action Lawsuit in Canada
3. Biometrics must respond to human aging
4. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
5. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
6. MinuteHound Announces Latest Biometric Time Keeping System Designed for Hospitals and Patient Clinics
7. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in Federal Biomet Hip Replacement Litigation
8. Biomet Hip Lawsuits News: Number of Cases Increases in Federal Courts, Reports Rottenstein Law Group LLP
9. Biomet Hip Lawsuit News: Claims in Federal Biomet Hip Replacement Litigation Surpass 650, Bernstein Liebhard LLP Reports
10. California Man Has Elevated Cobalt Levels and Possible Need for Revision Surgery After His Biomet Hip Implant Failed, Alleges Lawsuit Filed by Parker Waichman LLP
11. Biomet Hip Replacement News: Federal Multidistrict Litigation for Biomet Hip Lawsuits to Hold Status Conference, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: